Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
Malmström, Annika, Dr, Grønberg, Bjørn Henning, PhD, Marosi, Christine, MD, Stupp, Roger, MD, Frappaz, Didier, MD, Schultz, Henrik, MD, Abacioglu, Ufuk, MD, Tavelin, Björn, BSc, Lhermitte, Benoit, MD, Hegi, Monika E, PhD, Rosell, Johan, MSc, Henriksson, Roger, Prof
Published in The lancet oncology (01.09.2012)
Published in The lancet oncology (01.09.2012)
Get full text
Journal Article